0
Original Article |

Highly Penetrant Alterations of a Critical Region Including BDNF in Human Psychopathology and Obesity

Carl Ernst, PhD; Christian R. Marshall, PhD; Yiping Shen, PhD; Kay Metcalfe, MD; Jill Rosenfeld, PhD; Jennelle C. Hodge, PhD; Alcy Torres, MD; Ian Blumenthal, BSE; Colby Chiang, BA; Vamsee Pillalamarri, MS; Liam Crapper, BSc; Alpha B. Diallo, PhD; Douglas Ruderfer, MSc; Shahrin Pereira, BSc; Pamela Sklar, MD, PhD; Shaun Purcell, PhD; Robert S. Wildin, MD; Anne C. Spencer, MSc; Bradley F. Quade, MD, PhD; David J. Harris, MD; Emanuelle Lemyre, MD; Bai-lin Wu, PhD; Dimitri J. Stavropoulos, PhD; Michael T. Geraghty, MSc; Lisa G. Shaffer, PhD; Cynthia C. Morton, PhD; Stephen W. Scherer, PhD; James F. Gusella, PhD; Michael E. Talkowski, PhD
Arch Gen Psychiatry. 2012;69(12):1238-1246. doi:10.1001/archgenpsychiatry.2012.660.
Text Size: A A A
Published online

Context  Brain-derived neurotrophic factor (BDNF) is suspected of being a causative factor in psychiatric disorders based on case reports or studies involving large structural anomalies.

Objective  To determine the involvement of BDNF in human psychopathology.

Design  Case-control study.

Setting  Microarray-based comparative genomic hybridization data from 7 molecular diagnostic centers including 38 550 affected subjects and 28 705 unaffected subjects.

Patients  Subjects referred to diagnostic screening centers for microarray-based comparative genomic hybridization for physical or cognitive impairment.

Main Outcome Measures  Genomic copy number gains and losses.

Results  We report 5 individuals with psychopathology and genomic deletion of a critical region including BDNF. The defined critical region was never disrupted in control subjects or diagnostic cases without developmental abnormalities.

Conclusion  Hemizygosity of the BDNF region contributes to variable psychiatric phenotypes including anxiety, behavioral, and mood disorders.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Place holder to copy figure label and caption
Grahic Jump Location

Figure 1. All cases and controls (CTRL) with copy gains (blue) or losses (red) near the BDNF locus. Megabase marks (Mb) represent human genome reference 18 build coordinates. Green shading represents an identified critical region while darker green shading corresponds specifically to the genomic location of BDNF.

Place holder to copy figure label and caption
Grahic Jump Location

Figure 2. An approximately 2.5-megabase deletion in subject 2, including BDNF. Microarray-based comparative genomic hybridization results demonstrating a deletion on chromosome 11. Gray shading represents the predicted size of the deletion, while individual probes from the array are represented by black, white, or red dots. White probes represent decreased probe intensity from DNA from subject 2, reflecting copy loss. Human genome reference 18 build coordinates are shown on the x-axis.

Place holder to copy figure label and caption
Grahic Jump Location

Figure 3. Positive correlation of body mass index (BMI) (calculated as weight in kilograms divided by height in meters squared) with age in subjects with a BDNF deletion.

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs